CAMT NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Camtek Ltd · Technology · Semiconductor Equipment & Materials

Open interactive chart View report data
Latest close 147.8 USD
1.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -8.1% below the Trend Line and sits at 51.4% of its 52-week range. The latest completed week returned 1.1%, after a -3.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is volatility with 48/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 5d.

Setup score 34 out of 100
Latest Close 147.8 USD 24 Jul 2026
1W Return 1.1% latest completed week
4W Return -3.9% short-term follow-through
12W Return -20.8% quarterly tape
Trend Breadth 92.3% 48 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • 8 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.1% Latest completed week; four-week move -3.9%. Indicator stack 51/17 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 48/100 conviction; expected move 19.1%. News sentiment 55/100 55 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -8.1% below the Trend Line and sits at 51.4% of its 52-week range. The latest completed week returned 1.1%, after a -3.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5212-week average 0.76

12-week confirmation

Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.52Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers88 reversal markers

No recent accumulation markers. 8 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -3.9% over four weeks, -20.8% over 12 weeks, and 54.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.1%
4W-3.9%
12W-20.8%
26W2.9%
52W54.3%
Active trend streak0 weeks
Active weeks in one year48
Trend breadth92.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.04Latest activity-pressure read.
Pressure change-174.8%Four-week change in activity pressure.
Leadership0.71Latest relative-leadership reading.
RS change-76.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength36/100Blend of value, momentum, and quality. Underlying universe rank 65; rank 1 is best.
Value2/100Relative valuation strength. Underlying universe rank 99; rank 1 is best.
Quality81/100Profitability and accounting quality. Underlying universe rank 20; rank 1 is best.
Momentum87/100Medium-term price momentum. Underlying universe rank 14; rank 1 is best.
Growth31/100Revenue and earnings growth. Underlying universe rank 70; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework12/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
143.5x
Price divided by trailing earnings.
Price / sales
13.8x
Market value relative to trailing revenue.
EV / EBITDA
196.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
50.2%
Gross profit retained from each unit of revenue.
Operating margin
24.6%
Operating profit retained from revenue.
Free-cash-flow margin
31.3%
Free cash flow generated from revenue.
Return on invested capital
12.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.7%
Latest one-year revenue growth.
EPS growth
-62.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
7.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CAMT shows volatility options pressure with a 48/100 conviction score, put-call volume ratio of 1.39, expected move of 19.1%, and Sharemaestro trend signal inactive.

Conviction49/100
Expected move19.1%
Put/call volume1.39
Pressure-18
Speculation44
Volatility96
Trend agreement83
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 55 relevant articles.

19 positive · 32 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move19.1%Nearest-chain priced movement where available.
52-week drawdown-31.6%Distance below the 52-week high.
13-week volatility10.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+17.7%Week of 12 Jun.
Worst week-21.2%Week of 26 Jun.
Latest week+1.1%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains10
Flat weeks0
Modest losses1
Sharp losses8
Recent vol10.0%13-week weekly-return volatility.
Base vol8.8%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew6.9% / -7.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis50/100

Latest 12-week confirmation: trend 9/12, activity pressure 4/12, relative leadership 9/12.

Activity pressure 0.52; 8 reversal markers Factors50/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 55; Small Cap Core rank 100 SVQF12/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 640.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options58/100

CAMT shows volatility options pressure with a 48/100 conviction score, put-call volume ratio of 1.39, expected move of 19.1%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 19.1% Sentiment55/100

Weighted news tone is neutral across 55 relevant articles.

Migdal Insurance & Financial (CAMT) discloses 8.33% Camtek ownership in 13G/A Insiders50/100

No recent insider transaction evidence is stored.

 Earnings5d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026147.8 USD1.1%160.9 USD97.18 USD-1.040.711.9MOff
17 Jul 2026146.2 USD1.6%159.6 USD96.53 USD-1.00-1.592.6MOff
10 Jul 2026143.8 USD0.9%158.2 USD95.87 USD-0.75-6.832.5MOff
3 Jul 2026142.5 USD-7.3%157.1 USD95.21 USD-0.47-5.682.9MOn
26 Jun 2026153.7 USD-21.2%156.3 USD94.51 USD-0.382.992.6MOn
19 Jun 2026195.2 USD1.0%154.7 USD93.74 USD-0.3025.591.7MOn
12 Jun 2026193.3 USD17.7%151.3 USD92.69 USD-0.3829.142.1MOn
5 Jun 2026164.2 USD-4.3%148.1 USD91.66 USD-0.3013.673.3MOn
29 May 2026171.7 USD2.6%146.6 USD90.81 USD0.1314.481.4MOn
22 May 2026167.4 USD-0.6%145.0 USD89.89 USD0.5216.002.6MOn
15 May 2026168.3 USD-18.1%143.4 USD89.00 USD0.9219.294.2MOn
8 May 2026205.5 USD10.1%141.8 USD88.10 USD0.9946.741.7MOn
1 May 2026186.6 USD-8.1%138.6 USD86.95 USD0.8642.682.0MOn
24 Apr 2026203.0 USD12.9%136.2 USD85.93 USD0.7559.761.7MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.